2-[3-[3-[2-[4-tert-butyl-2-(trideuteriomethyl)phenyl]-6-(1,3,4-trideuterio-5,5,8,8-tetramethyl-6,7-dihydronaphthalen-2-yl)phenyl]-2H-benzimidazol-2-id-1-yl]benzene-2-id-1-yl]oxy-5,6,7,8-tetradeuterio-9-[4-(1,1-dideuterio-2,2-dimethylpropyl)-2-pyridinyl]-1H-carbazol-1-ide;platinum

C66H65N4OPt-3 — CID 176756736

IUPAC2-[3-[3-[2-[4-tert-butyl-2-(trideuteriomethyl)phenyl]-6-(1,3,4-trideuterio-5,5,8,8-tetramethyl-6,7-dihydronaphthalen-2-yl)phenyl]-2H-benzimidazol-2-id-1-yl]benzene-2-id-1-yl]oxy-5,6,7,8-tetradeuterio-9-[4-(1,1-dideuterio-2,2-dimethylpropyl)-2-pyridinyl]-1H-carbazol-1-ide;platinum
SMILES[2H]c1c([2H])c2c(c([2H])c1-c1cccc(-c3ccc(C(C)(C)C)cc3C([2H])([2H])[2H])c1N1[CH-]N(c3[c-]c(Oc4[c-]c5c(cc4)c4c([2H])c([2H])c([2H])c([2H])c4n5-c4cc(C([2H])([2H])C(C)(C)C)ccn4)ccc3)c3ccccc31)C(C)(C)CCC2(C)C.[Pt]
InChIInChI=1S/C66H65N4O.Pt/c1-43-36-46(64(5,6)7)27-29-50(43)54-22-17-21-51(45-26-31-55-56(38-45)66(10,11)34-33-65(55,8)9)62(54)69-42-68(58-24-14-15-25-59(58)69)47-18-16-19-48(39-47)71-49-28-30-53-52-20-12-13-23-57(52)70(60(53)40-49)61-37-44(32-35-67-61)41-63(2,3)4;/h12-32,35-38,42H,33-34,41H2,1-11H3;/q-3;/i1D3,12D,13D,20D,23D,26D,31D,38D,41D2;
InChIKeyPOERCINZPYGHLR-NPRKSXBZSA-N
MW1137.42 g/mol
LogP17.86
Rot. Bonds9

About 2-[3-[3-[2-[4-tert-butyl-2-(trideuteriomethyl)phenyl]-6-(1,3,4-trideuterio-5,5,8,8-tetramethyl-6,7-dihydronaphthalen-2-yl)phenyl]-2H-benzimidazol-2-id-1-yl]benzene-2-id-1-yl]oxy-5,6,7,8-tetradeuterio-9-[4-(1,1-dideuterio-2,2-dimethylpropyl)-2-pyridinyl]-1H-carbazol-1-ide;platinum

2-[3-[3-[2-[4-tert-butyl-2-(trideuteriomethyl)phenyl]-6-(1,3,4-trideuterio-5,5,8,8-tetramethyl-6,7-dihydronaphthalen-2-yl)phenyl]-2H-benzimidazol-2-id-1-yl]benzene-2-id-1-yl]oxy-5,6,7,8-tetradeuterio-9-[4-(1,1-dideuterio-2,2-dimethylpropyl)-2-pyridinyl]-1H-carbazol-1-ide;platinum (PubChem CID 176756736) has the molecular formula C66H65N4OPt-3 and a molecular weight of 1137.42 g/mol. Its IUPAC name is 2-[3-[3-[2-[4-tert-butyl-2-(trideuteriomethyl)phenyl]-6-(1,3,4-trideuterio-5,5,8,8-tetramethyl-6,7-dihydronaphthalen-2-yl)phenyl]-2H-benzimidazol-2-id-1-yl]benzene-2-id-1-yl]oxy-5,6,7,8-tetradeuterio-9-[4-(1,1-dideuterio-2,2-dimethylpropyl)-2-pyridinyl]-1H-carbazol-1-ide;platinum.

Molecular Properties

Compound Name2-[3-[3-[2-[4-tert-butyl-2-(trideuteriomethyl)phenyl]-6-(1,3,4-trideuterio-5,5,8,8-tetramethyl-6,7-dihydronaphthalen-2-yl)phenyl]-2H-benzimidazol-2-id-1-yl]benzene-2-id-1-yl]oxy-5,6,7,8-tetradeuterio-9-[4-(1,1-dideuterio-2,2-dimethylpropyl)-2-pyridinyl]-1H-carbazol-1-ide;platinum
PubChem CID176756736
Molecular FormulaC66H65N4OPt-3
Molecular Weight1137.42 g/mol
Exact Mass1136.56
IUPAC Name2-[3-[3-[2-[4-tert-butyl-2-(trideuteriomethyl)phenyl]-6-(1,3,4-trideuterio-5,5,8,8-tetramethyl-6,7-dihydronaphthalen-2-yl)phenyl]-2H-benzimidazol-2-id-1-yl]benzene-2-id-1-yl]oxy-5,6,7,8-tetradeuterio-9-[4-(1,1-dideuterio-2,2-dimethylpropyl)-2-pyridinyl]-1H-carbazol-1-ide;platinum
SMILES[2H]c1c([2H])c2c(c([2H])c1-c1cccc(-c3ccc(C(C)(C)C)cc3C([2H])([2H])[2H])c1N1[CH-]N(c3[c-]c(Oc4[c-]c5c(cc4)c4c([2H])c([2H])c([2H])c([2H])c4n5-c4cc(C([2H])([2H])C(C)(C)C)ccn4)ccc3)c3ccccc31)C(C)(C)CCC2(C)C.[Pt]
InChIInChI=1S/C66H65N4O.Pt/c1-43-36-46(64(5,6)7)27-29-50(43)54-22-17-21-51(45-26-31-55-56(38-45)66(10,11)34-33-65(55,8)9)62(54)69-42-68(58-24-14-15-25-59(58)69)47-18-16-19-48(39-47)71-49-28-30-53-52-20-12-13-23-57(52)70(60(53)40-49)61-37-44(32-35-67-61)41-63(2,3)4;/h12-32,35-38,42H,33-34,41H2,1-11H3;/q-3;/i1D3,12D,13D,20D,23D,26D,31D,38D,41D2;
InChIKeyPOERCINZPYGHLR-NPRKSXBZSA-N
XLogP17.86
TPSA33.53 Ų
H-Bond Donors
H-Bond Acceptors5
Rotatable Bonds9
Heavy Atoms72
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 5001137.42
LogP ≤ 517.86
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 105

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Carbo_cation/anion', 'substructure': 'N/A'}

Analyze 2-[3-[3-[2-[4-tert-butyl-2-(trideuteriomethyl)phenyl]-6-(1,3,4-trideuterio-5,5,8,8-tetramethyl-6,7-dihydronaphthalen-2-yl)phenyl]-2H-benzimidazol-2-id-1-yl]benzene-2-id-1-yl]oxy-5,6,7,8-tetradeuterio-9-[4-(1,1-dideuterio-2,2-dimethylpropyl)-2-pyridinyl]-1H-carbazol-1-ide;platinum with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-[3-[3-[2-[4-tert-butyl-2-(trideuteriomethyl)phenyl]-6-(1,3,4-trideuterio-5,5,8,8-tetramethyl-6,7-dihydronaphthalen-2-yl)phenyl]-2H-benzimidazol-2-id-1-yl]benzene-2-id-1-yl]oxy-5,6,7,8-tetradeuterio-9-[4-(1,1-dideuterio-2,2-dimethylpropyl)-2-pyridinyl]-1H-carbazol-1-ide;platinum?
The IUPAC name of 2-[3-[3-[2-[4-tert-butyl-2-(trideuteriomethyl)phenyl]-6-(1,3,4-trideuterio-5,5,8,8-tetramethyl-6,7-dihydronaphthalen-2-yl)phenyl]-2H-benzimidazol-2-id-1-yl]benzene-2-id-1-yl]oxy-5,6,7,8-tetradeuterio-9-[4-(1,1-dideuterio-2,2-dimethylpropyl)-2-pyridinyl]-1H-carbazol-1-ide;platinum (CID 176756736) is 2-[3-[3-[2-[4-tert-butyl-2-(trideuteriomethyl)phenyl]-6-(1,3,4-trideuterio-5,5,8,8-tetramethyl-6,7-dihydronaphthalen-2-yl)phenyl]-2H-benzimidazol-2-id-1-yl]benzene-2-id-1-yl]oxy-5,6,7,8-tetradeuterio-9-[4-(1,1-dideuterio-2,2-dimethylpropyl)-2-pyridinyl]-1H-carbazol-1-ide;platinum.
What is the SMILES notation for 2-[3-[3-[2-[4-tert-butyl-2-(trideuteriomethyl)phenyl]-6-(1,3,4-trideuterio-5,5,8,8-tetramethyl-6,7-dihydronaphthalen-2-yl)phenyl]-2H-benzimidazol-2-id-1-yl]benzene-2-id-1-yl]oxy-5,6,7,8-tetradeuterio-9-[4-(1,1-dideuterio-2,2-dimethylpropyl)-2-pyridinyl]-1H-carbazol-1-ide;platinum?
The canonical SMILES for 2-[3-[3-[2-[4-tert-butyl-2-(trideuteriomethyl)phenyl]-6-(1,3,4-trideuterio-5,5,8,8-tetramethyl-6,7-dihydronaphthalen-2-yl)phenyl]-2H-benzimidazol-2-id-1-yl]benzene-2-id-1-yl]oxy-5,6,7,8-tetradeuterio-9-[4-(1,1-dideuterio-2,2-dimethylpropyl)-2-pyridinyl]-1H-carbazol-1-ide;platinum is [2H]c1c([2H])c2c(c([2H])c1-c1cccc(-c3ccc(C(C)(C)C)cc3C([2H])([2H])[2H])c1N1[CH-]N(c3[c-]c(Oc4[c-]c5c(cc4)c4c([2H])c([2H])c([2H])c([2H])c4n5-c4cc(C([2H])([2H])C(C)(C)C)ccn4)ccc3)c3ccccc31)C(C)(C)CCC2(C)C.[Pt].
What is the InChIKey of 2-[3-[3-[2-[4-tert-butyl-2-(trideuteriomethyl)phenyl]-6-(1,3,4-trideuterio-5,5,8,8-tetramethyl-6,7-dihydronaphthalen-2-yl)phenyl]-2H-benzimidazol-2-id-1-yl]benzene-2-id-1-yl]oxy-5,6,7,8-tetradeuterio-9-[4-(1,1-dideuterio-2,2-dimethylpropyl)-2-pyridinyl]-1H-carbazol-1-ide;platinum?
The InChIKey is POERCINZPYGHLR-NPRKSXBZSA-N. The full InChI is InChI=1S/C66H65N4O.Pt/c1-43-36-46(64(5,6)7)27-29-50(43)54-22-17-21-51(45-26-31-55-56(38-45)66(10,11)34-33-65(55,8)9)62(54)69-42-68(58-24-14-15-25-59(58)69)47-18-16-19-48(39-47)71-49-28-30-53-52-20-12-13-23-57(52)70(60(53)40-49)61-37-44(32-35-67-61)41-63(2,3)4;/h12-32,35-38,42H,33-34,41H2,1-11H3;/q-3;/i1D3,12D,13D,20D,23D,26D,31D,38D,41D2;.
What are the key properties of 2-[3-[3-[2-[4-tert-butyl-2-(trideuteriomethyl)phenyl]-6-(1,3,4-trideuterio-5,5,8,8-tetramethyl-6,7-dihydronaphthalen-2-yl)phenyl]-2H-benzimidazol-2-id-1-yl]benzene-2-id-1-yl]oxy-5,6,7,8-tetradeuterio-9-[4-(1,1-dideuterio-2,2-dimethylpropyl)-2-pyridinyl]-1H-carbazol-1-ide;platinum?
2-[3-[3-[2-[4-tert-butyl-2-(trideuteriomethyl)phenyl]-6-(1,3,4-trideuterio-5,5,8,8-tetramethyl-6,7-dihydronaphthalen-2-yl)phenyl]-2H-benzimidazol-2-id-1-yl]benzene-2-id-1-yl]oxy-5,6,7,8-tetradeuterio-9-[4-(1,1-dideuterio-2,2-dimethylpropyl)-2-pyridinyl]-1H-carbazol-1-ide;platinum has a molecular weight of 1137.42 g/mol, XLogP of 17.86, 9 rotatable bonds, 0 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[3-[3-[2-[4-tert-butyl-2-(trideuteriomethyl)phenyl]-6-(1,3,4-trideuterio-5,5,8,8-tetramethyl-6,7-dihydronaphthalen-2-yl)phenyl]-2H-benzimidazol-2-id-1-yl]benzene-2-id-1-yl]oxy-5,6,7,8-tetradeuterio-9-[4-(1,1-dideuterio-2,2-dimethylpropyl)-2-pyridinyl]-1H-carbazol-1-ide;platinum is sourced from PubChem (CID 176756736), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).